SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001114220-17-000022
Filing Date
2017-08-01
Accepted
2017-08-01 16:27:22
Documents
1
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150161922803370.html 4  
1 FORM 4 wf-form4_150161922803370.xml 4 3665
  Complete submission text file 0001114220-17-000022.txt   5028
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KERYX BIOPHARMACEUTICALS INC 1 MARINA PARK DR., 10TH FLOOR BOSTON MA 02210
Business Address
Holmes Scott A (Reporting) CIK: 0001537670 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 17997070